BMO Capital Markets has initiated coverage of Shopify (Shopify Stock Quote, Chart, News, Analysts, Financials NYSE:SHOP) with an “Outperform” rating and a $120.00 price target, modestly above the Wall Street consensus target of $117.90, saying the company is well-positioned to navigate tariff-related disruption while continuing to grow across multiple fronts.
On March 25, analyst Thanos Moschopoulos said Shopify’s platform gives merchants a level of agility that should help the company hold up better than peers if tariff pressures intensify.
“While tariffs create near-term risk, we believe SHOP’s core strength is the agility that its platform provides to merchants,” he said. “In our view, tariff-related disruption will make this competitive differentiator all the more relevant, driving accelerated share gains.”
Moschopoulos also pointed to Shopify’s AI initiatives as a potential earnings tailwind, adding to the firm’s positive long-term view on the stock.
Shopify is scheduled to report first-quarter results on May 8. Analyst consensus calls for revenue of $2.33-billion and earnings per share of $0.26.
-30-
Haywood Securities analyst Neal Gilmer says lower Canadian cannabis market share is weighing on Tilray Brands (Tilray Brands Stock Quote,… [Read More]
National Bank Financial analyst Baltej Sidhu says Anaergia’s (Anaergia Stock Quote, Chart, News, Analysts, Financials TSX:ANRG) divestiture of two legacy… [Read More]
RBC assistant chief economist Cynthia Leach says the public sector is playing a larger role in Canada’s investment boom than… [Read More]
Research Capital analyst Andre Uddin says Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:EPRX) reported another strong… [Read More]
Roth Capital Partners analyst Craig Irwin says VersaBank (VersaBank Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) is nearing a potential… [Read More]
Roth Capital Partners analyst Max Masucci says Rapid Micro Biosystems (Rapid Micro Biosystems Stock Quote, Chart, News, Analysts, Financials NASDAQ:RPID)… [Read More]